Drug company experts advised staff to withhold data about SSRI use in children
about
Challenges in coding adverse events in clinical trials: a systematic reviewAre pediatric Open Access journals promoting good publication practice? An analysis of author instructions.Financial conflicts of interest in psychiatryThe Canadian agency for the oversight of research involving humans: a reform proposal.Registering randomized clinical trials and the case for CONSORTNetwork meta-analyses performed by contracting companies and commissioned by industry.Quality, bias and service user experience in healthcare: 10 years of mental health guidelines at the UK National Collaborating Centre for Mental Health.Clinical trial transparency: many gains but access to evidence for new medicines remains imperfect.Manic switches induced by antidepressants: an umbrella review comparing randomized controlled trials and observational studies.Medical science and societyCompounding risks to patients: selective disclosure is not an option.Clinical trials in Canada: whose interests are paramount?Spilling the beans on the pharmaceutical industry.Commentary: Science scandal or ethics scandal? Olivieri redux.Ethics in the discipline(s) of bioethics.Conflicted medical journals and the failure of trust.Ethics and the pharmaceutical industry.
P2860
Q26851713-0DCB87CB-68F2-4C69-B80F-096851A9A456Q30484925-DC1CEC01-56DD-4DAD-9225-D6473ECAAAFFQ35652906-A3E92D2C-CF03-4DBC-9DFF-1EA56497710CQ36505156-B1B727CB-B5BD-4B2E-B10F-321BCB8F0DA8Q36841321-59A61F35-BCB9-43A5-A53C-8F0D7D1665D6Q37440674-BCF795A0-05EB-4440-8749-E65DB3F70BF0Q37949399-B076EBE0-4EE9-488A-974F-CFBF406562A5Q38614034-F1997BC3-134B-47D7-92E0-EF359183F13DQ39017799-B412F4A6-FAFB-43DB-B8D1-87BA1E47A3A2Q42424974-6BD660A0-07C0-42C3-B2A9-EC4E2426B3F0Q43226797-8B6BFC2A-60A2-4605-AF45-D2612A2E85A7Q45172180-4FFC59DC-A249-4C10-9DFC-5611881799E1Q45757072-17FC3B00-34F2-4AE5-8FE6-7C80F2D564AFQ48550171-FDA25FFD-1DFE-4FE7-9F1D-BB97CF1ECEC4Q48616286-2E76D3CF-1A9A-46C7-99BA-37C3E7EF6898Q48920907-E1F90AC2-6401-44E7-B8EC-4511536F1847Q50630795-629A17E8-0B9E-43E0-8A3A-ED1BB85A0CE9
P2860
Drug company experts advised staff to withhold data about SSRI use in children
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Drug company experts advised staff to withhold data about SSRI use in children
@ast
Drug company experts advised staff to withhold data about SSRI use in children
@en
Drug company experts advised staff to withhold data about SSRI use in children
@nl
type
label
Drug company experts advised staff to withhold data about SSRI use in children
@ast
Drug company experts advised staff to withhold data about SSRI use in children
@en
Drug company experts advised staff to withhold data about SSRI use in children
@nl
prefLabel
Drug company experts advised staff to withhold data about SSRI use in children
@ast
Drug company experts advised staff to withhold data about SSRI use in children
@en
Drug company experts advised staff to withhold data about SSRI use in children
@nl
P356
P1476
Drug company experts advised staff to withhold data about SSRI use in children
@en
P2093
Wayne Kondro
P356
10.1503/CMAJ.1040213
P407
P577
2004-03-02T00:00:00Z